Avecho Biotechnology Ltd has released a press release.
March 2021 Quarterly Activities Report & Appendix 4C
Filed with ASX ·
6ix hasn’t read this filing yet.
Avecho Biotechnology Limited on 6ix
Story so far
Earlier from Avecho Biotechnology
- Avecho receives ethics approval for CBD human trial
- AVE receives firm commitment to raise $5.06 via placement
- December 2020 Quarterly Activities Report & Appendix 4C
- AVE begins Human Trial on CBD product
- Improved Propofol TPM Formulation Passes Toxicology Study
Later from Avecho Biotechnology
- Avecho completes pharmaceutical CBD soft-gel product
- TGA meeting for CBD soft-gel targeting insomnia
- AB Vista to explore new TPM applications for Animal Health
- Chairs Address and CEO Presentation
- Avecho to Present New CBD Data at GCI Virtual Summit
Follow Avecho Biotechnology into a list and get an email when it puts out news.
Follow Avecho Biotechnology